Cita APA

Yap, T. A., Winter, J. N., Giulino-Roth, L., Longley, J., Lopez, J., Michot, J., . . . Johnson, P. W. (2019). Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors. Clin Cancer Res.

Chicago Style Citation

Yap, Timothy A., et al. "Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients With Advanced Hematologic and Solid Tumors." Clin Cancer Res 2019.

Cita MLA

Yap, Timothy A., et al. "Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients With Advanced Hematologic and Solid Tumors." Clin Cancer Res 2019.